Launched on May 27, the nineth video of the series explains why people with heart disease may have complications when infected with Sars-CoV-2.


Video Script:
Emiliano Medei (Federal University of Rio de Janeiro, UFRJ)

Project Coordination:
Débora Foguel (Federal University of Rio de Janeiro, UFRJ)

Video Production Team:
Lucia Bianconi (Federal University of Rio de Janeiro, UFRJ) – team leader
Mateus Malta Fleury (Mathematics student, University of Brasília, UnB)

Evaluation Committee:
Helena B. Nader (Vice-President, Brazilian Academy of Sciences, ABC)
João Batista Calixto (Vice-President for the South Region, Brazilian Academy of Sciences, ABC)
Mauro Teixeira (Vice-President for the Minas Gerais and Midwest Region, Brazilian Academy of Sciences, ABC)
Lucile Winter (Board of Directors, Brazilian Society for the Advancement of Science, SBPC)


Watch the Video (in Portuguese):


1. Dong E, Du H and Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. Feb 19, 2020. doi: 10.1016/S1473-3099(20)30120-1.
2. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA, Drosten C and Pöhlmann S. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. March 5, 2020. doi: 10.1016/j.cell.2020.02.052.
3. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y and Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov. bioRxiv. January 26, 2020. doi: 10.1101/2020.01.26.919985.
4. Tikellis C and Thomas MC. Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease. Int J Pept.2012;2012:256294-256294.
5. Zhang H, Penninger JM, Li Y, Zhong N and Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. March 3, 2020. doi: 10.1007/s00134-020-05985-9.
6. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X and Peng Z. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061-1069.
7. Zheng Y-Y, Ma Y-T, Zhang J-Y and Xie X. COVID-19 and the cardiovascular system. Nat Rev Cardiol. March 5, 2020. doi: 10.1038/s41569-020-0360-523.
8. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H and Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. March 11, 2020. doi: 10.1016/S0140-6736(20)30566-3.
9. Hu H, Ma F, Wei X and Fang Y. Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin. Eur Heart J. March 16, 2020. doi: 10.1093/eurheartj/ehaa190.
10. Zeng JH, Liu YX, Yuan J, Wang FX, Wu WB, Li JX, Wang LF, Gao H, Wang Y, Dong CF, Li YJ, Xie XJ, Feng C and Liu L. First Case of COVID-19 Infection with Fulminant Myocarditis Complication: Case Report and Insights. preprints. 2020; 2020030180. doi:10.20944/preprints202003.0180.v1.
11. Centers for Disease Control and Prevention. Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19).
12. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. March 13, 2020.
13. Oudit GY, Kassiri Z, Jiang C, Liu PP, Poutanen SM, Penninger JM and Butany J. SARScoronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. Eur J Clin Invest. 2009;39:618-625.
14. Booth CM, Matukas LM, Tomlinson GA, Rachlis AR, Rose DB, Dwosh HA, Walmsley SL, Mazzulli T, Avendano M, Derkach P, Ephtimios IE, Kitai I, Mederski BD, Shadowitz SB, Gold WL, Hawryluck LA, Rea E, Chenkin JS, Cescon DW, Poutanen SM and Detsky AS. Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area. JAMA. 2003;289:2801-2809.